User menu

Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study

Bibliographic reference Beck, Raphaël ; Eeckhoudt, Stéphane ; Knoops, Laurent ; Pedrosa, Rozangela Curi ; Dejeans, Nicolas ; et. al. Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study. In: Investigational New Drugs : the journal of new anti-cancer agents, Vol. 29, no. 5, p. 891-900 (2011)
Permanent URL
  1. Behrend L., Henderson G., Zwacka R.M., Reactive oxygen species in oncogenic transformation, 10.1042/bst0311441
  2. Wu Wen-Sheng, The signaling mechanism of ROS in tumor progression, 10.1007/s10555-006-9037-8
  3. Sun Yi, Oberley Larry W., Elwell James H., Sierra-Rivera Elaine, Antioxidant enzyme activities in normal and transformed mouse liver cells, 10.1002/ijc.2910440615
  4. Verrax Julien, Cadrobbi Julie, Marques Carole, Taper Henryk, Habraken Yvette, Piette Jacques, Calderon Pedro Buc, Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death, 10.1023/b:appt.0000018804.26026.1a
  5. Trachootham Dunyaporn, Zhou Yan, Zhang Hui, Demizu Yusuke, Chen Zhao, Pelicano Helene, Chiao Paul J., Achanta Geetha, Arlinghaus Ralph B., Liu Jinsong, Huang Peng, Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate, 10.1016/j.ccr.2006.08.009
  6. Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88(3):1052–1061
  7. Chandra J., Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells, 10.1182/blood-2003-02-0562
  8. Verrax Julien, Cadrobbi Julie, Delvaux Marianne, Jamison James M., Gilloteaux Jacques, Summers Jack L., Taper Henryk S., Buc Calderon Pedro, The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy, 10.1016/s0223-5234(03)00082-5
  9. Verrax Julien, Delvaux Marianne, Beghein Nelson, Taper Henryk, Gallez Bernard, Buc Calderon Pedro, Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. Anin vitrocomparative study, 10.1080/10715760500097906
  10. Verrax Julien, Stockis Julie, Tison Aurélie, Taper Henryk S., Calderon Pedro Buc, Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice, 10.1016/j.bcp.2006.05.025
  11. Verrax Julien, Vanbever Stéphanie, Stockis Julie, Taper Henryk, Calderon Pedro Buc, Role of glycolysis inhibition and poly(ADP-ribose) polymerase activation in necrotic-like cell death caused by ascorbate/menadione-induced oxidative stress in K562 human chronic myelogenous leukemic cells, 10.1002/ijc.22439
  12. Dejeans Nicolas, Tajeddine Nicolas, Beck Raphaël, Verrax Julien, Taper Henryk, Gailly Philippe, Calderon Pedro Buc, Endoplasmic reticulum calcium release potentiates the ER stress and cell death caused by an oxidative stress in MCF-7 cells, 10.1016/j.bcp.2009.12.009
  13. Beck Raphael, Verrax Julien, Gonze Thomas, Zappone Marianne, Pedrosa Rozangela Curi, Taper Henryk, Feron Olivier, Calderon Pedro Buc, Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death, 10.1016/j.bcp.2008.10.019
  14. Verrax J., Pedrosa R., Beck R., Dejeans N., Taper H., Calderon P., In Situ Modulation of Oxidative Stress: A Novel and Efficient Strategy to Kill Cancer Cells, 10.2174/092986709788186057
  15. Daley G., Van Etten R., Baltimore D, Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome, 10.1126/science.2406902
  16. Elefanty AG, Hariharan IK, Cory S (1990) bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J 9(4):1069–1078
  17. Heisterkamp Nora, Jenster Guido, ten Hoeve Joanne, Zovich Daniel, Pattengale Paul K., Groffen John, Acute leukaemia in bcr/abl transgenic mice, 10.1038/344251a0
  18. Kelliher M. A., McLaughlin J., Witte O. N., Rosenberg N., Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL., 10.1073/pnas.87.17.6649
  19. Lugo T., Pendergast A., Muller A., Witte O., Tyrosine kinase activity and transformation potency of bcr-abl oncogene products, 10.1126/science.2408149
  20. Druker Brian J., Tamura Shu, Buchdunger Elisabeth, Ohno Sayuri, Segal Gerald M., Fanning Shane, Zimmermann Jürg, Lydon Nicholas B., Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells, 10.1038/nm0596-561
  21. Jiang X., Saw K. M., Eaves A., Eaves C., Instability of BCR-ABL Gene in Primary and Cultured Chronic Myeloid Leukemia Stem Cells, 10.1093/jnci/djk150
  22. Shah Neil P., Nicoll John M., Nagar Bhushan, Gorre Mercedes E., Paquette Ronald L., Kuriyan John, Sawyers Charles L., Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia, 10.1016/s1535-6108(02)00096-x
  23. An WG, Schulte TW, Neckers LM (2000) The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. Cell Growth Differ 11(7):355–360
  24. Baudhuin P, Beaufay H, Rahman-Li Y, Sellinger OZ, Wattiaux R, Jacques P, De Duve C, Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, d-amino acid oxidase and catalase in rat-liver tissue, 10.1042/bj0920179
  25. Ilaria RL Jr, Van Etten RA (1995) The SH2 domain of P210BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells. Blood 86(10):3897–3904
  26. Peters D. G., Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia, 10.1182/blood.v97.5.1404
  27. Toth K M, Clifford D P, Berger E M, White C W, Repine J E, Intact human erythrocytes prevent hydrogen peroxide-mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells., 10.1172/jci111414
  28. Agar N S, Sadrzadeh S M, Hallaway P E, Eaton J W, Erythrocyte catalase. A somatic oxidant defense?, 10.1172/jci112294
  29. Winterbourn C C, Stern A, Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical., 10.1172/jci113230
  30. Chen Q., Espey M. G., Krishna M. C., Mitchell J. B., Corpe C. P., Buettner G. R., Shacter E., Levine M., Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues, 10.1073/pnas.0506390102
  31. Beck R., Verrax J., Dejeans N., Taper H., Calderon P. B., Menadione Reduction by Pharmacological Doses of Ascorbate Induces an Oxidative Stress That Kills Breast Cancer Cells, 10.1177/1091581809333139
  32. Trachootham Dunyaporn, Alexandre Jerome, Huang Peng, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, 10.1038/nrd2803
  33. Wondrak Georg T., Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities, 10.1089/ars.2009.2541